Sign In
Buy RHHBY
$54.64
-0.630 (-1.14%)
At Close: Jul 31, 2026
New Data for Genentech's Hemlibra (emicizumab-kxwh) Reinforce Safety Profile in People With Hemophilia A
01:00am, Monday, 19'th Jul 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced results from the final analysis of the Phase IIIb STASEY study, which
AVZ Minerals boosts Roche Dure lithium and tin ore reserves by 41.6%
11:38pm, Tuesday, 13'th Jul 2021
AVZ Minerals Ltd's (ASX:AVZ) (OTCMKTS:AZZVF) (FRA:3A2) recent ore reserve estimate has resulted in an increase of 41.6% at Roche Dure deposit of the Manono Lithium and Tin Project in the Democratic Re
Late-Stage Clinical Study Readouts Biotech Investors Should Watch
02:04pm, Sunday, 11'th Jul 2021
Several drugmakers have important clinical trial updates on the way.
Basel, 09 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the cobas® MTB and cobas® MTB-RIF/INH tests for use on the cobas® 6800/8800 Systems are included as part of the updated
WHO Guidelines Put Spotlight on Arthritis Drugs Actemra & Kevzara
12:02pm, Thursday, 08'th Jul 2021
The latest guideline update by the WHO includes the use of arthritis drugs like Roche's (RHHBY) Actemra and Sanofi's (SNY) Kevzara for the treatment of severe COVID-19.
WHO Recommends IL-6 Drugs From Sanofi, Roche For Critically-Ill COVID-19 Patients
11:47am, Wednesday, 07'th Jul 2021
The World Health Organization (WHO) has endorsed Interleukin-6 (IL-6) receptor antagonists combined with corticosteroids to treat severe COVID-19 cases. Patients severely or critically ill with COVI
WHO recommends Roche, Sanofi/Regeneron drugs as COVID-19 treatments, calls for lower prices
07:48am, Wednesday, 07'th Jul 2021
The World Health Organization began recommending the use of medicines called interleukin-6 receptor blockers as COVID-19 treatments for the severely ill, based on the findings of a large clinical stud
Veteran strategist David Roche explains why he thinks it's 'too risky' to own Chinese tech stocks
02:42am, Monday, 05'th Jul 2021
Roche said uncertainties are coming from an ongoing regulatory crackdown in China and the geopolitical rivalry between Washington and Beijing.
Basel, 02 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new data from its haemophilia A clinical programme will be presented at the virtual International Society on Thrombosis an
Roche to cut 300-400 product development jobs - Blick
06:23am, Thursday, 01'st Jul 2021
Roche plans to cut 300-400 jobs this year at product development (PD) sites, company executives including Chief Medical Officer Levi Garraway said during a recorded video call with employees obtained
This Risky Micro-Cap Could Pay Off Big
08:31am, Wednesday, 30'th Jun 2021
Pieris Pharmaceuticals is introducing a whole new class of drugs to the marketplace.
Novartis fights Roche in $210 million U.S. dispute over licensing fees
09:57am, Tuesday, 29'th Jun 2021
Novartis wants Roche to return $210 million after accusing its Swiss rival of inappropriately pocketing fees from a 16-year-old patent licensing agreement, according to a U.S. District Court lawsuit.
Top investment strategist David Roche warns the Fed could burst a market 'bubble'
12:13am, Tuesday, 29'th Jun 2021
As the S&P 500 notches record highs, veteran investor David Roche says investors should be wary of the bubble bursting.
Roche's (RHHBY) Actemra Gets FDA Emergency Nod for COVID-19
12:47pm, Monday, 28'th Jun 2021
The FDA issues an Emergency Use Authorization for Roche's (RHHBY) Actemra for the treatment of COVID-19 in hospitalized adults and pediatric patients.
Roche's Enspryng Wins European Approval For Spinal Cord, Optic Nerve Inflammation Disorder
08:30am, Monday, 28'th Jun 2021
The European Commission has approved Roche Holding AG's (OTC: RHHBY) injectable Enspryng for adults and adolescents with neuromyelitis optica spectrum disorder (NMOSD). The approval for the treatme
